6/1 โ ๐ FDA policy watch
Streamlined nonclinical safety requirements for oncology biologics and ADCs could meaningfully compress preclinical timelines, accelerating IND filings and reducing early-stage development costs. This sig...
#FDA#biotech#regulatory
6/1 โ ๐ RegulaEdge signal accuracy โ last 90 days
20 of 54 HIGH/MED signals called correctly at T+5 (37%)
Methodology: UP signal correct if price >+1% at T+5. DOWN correct if <-1%.
Full track record: https://t.co/4ZHsISbGH2
#quant#biotech#FDA
6/1 โ ๐ด HIGH IMPACT โ SEC 8-K Corporate Disclosure
$RLYB โ
Rallybio Corp (RLYB) has announced a reverse merger with priva...
Source: https://t.co/urCW8PsTjn
Full signal: https://t.co/kvdFdDt87N
#biotech#SEC#investing
5/29 โ ๐ FDA policy watch
Patient input gathered here shapes future FDA guidance on clinical endpoints for chronic wound therapies, potentially clarifying approval pathways for an underserved indication. Investors in wound care b...
#FDA#biotech#regulatory
5/29 โ ๐ This week in FDA & CMS
APGE โ โ 8-K: Apogee Therapeutics, Inc. (APGE) โฆ
OTLK โ โ 8-K: Outlook Therapeutics, Inc. (OTLK)โฆ
$APGE โ โ 8-K: Apogee Therapeutics, Inc. (APGE) โฆ
Full signals: https://t.co/4ZHsISbGH2
#FDA#biotech#investing
5/27 โ ๐ FDA policy watch
Legacy DESI closures signal FDA housekeeping, not pipeline risk. Investors should note tightening enforcement on unapproved legacy combinations, but market impact is minimal with no major commercial prod...
#FDA#biotech#regulatory
5/27 โ โฐ PDUFA in 3 days
$ALDX โ Aldeyra Therapeutics, Inc.
Signs and Symptoms of Dry Eye Disease Lexington, Mass, Aldeyra Therapeutics, Inc.. FDA action date: May 30.
Full calendar: https://t.co/9XUFW38jqn
#PDUFA#biotech#FDA
5/22 โ ๐ FDA policy watch
Routine bioequivalence guidance updates signal stable generic drug pathways, posing no disruption to ANDA timelines or approval velocity. Predictable FDA procedural activity supports steady generic pipel...
#FDA#biotech#regulatory
5/22 โ ๐ This week in FDA & CMS
$WVE โ โ 8-K: Wave Life Sciences Ltd. (WVE) โ 2026-โฆ
OTLK โ โ 8-K: Outlook Therapeutics, Inc. (OTLK) โ 2โฆ
AORT โ โ 8-K: Artivion, Inc. (AORT) โ 2026-05-18
Full signals: https://t.co/4ZHsIScewA
#FDA#biotech#investing
5/22 โ ๐ก MED IMPACT โ FDA Notice
$MRNA โ
FDA has scheduled a Vaccines and Related Biological Products Advisory Comm...
Source: https://t.co/LtVlID5d8t
Full signal: https://t.co/1fWcgD84LH
#biotech#FDA#investing
5/15 โ ๐ง How it works
"We parse every Federal Register drop in real time, run it through our policy impact engine, and surface the trades that matter before the Street catches up."
https://t.co/jYu4w7T3aZ
#buildinpublic#fintech#FDA